Page last updated: 2024-09-04

bazedoxifene and Fatty Liver

bazedoxifene has been researched along with Fatty Liver in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmed, M; Barrera, J; Chambliss, KL; McDonald, JG; Mineo, C; Shaul, PW; Tanigaki, K; Thompson, B1

Other Studies

1 other study(ies) available for bazedoxifene and Fatty Liver

ArticleYear
Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract.
    American journal of physiology. Endocrinology and metabolism, 2014, Aug-01, Volume: 307, Issue:3

    Topics: Abdominal Fat; Adiposity; Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Fatty Liver; Female; Indoles; Insulin Resistance; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Organ Size; Ovariectomy; Selective Estrogen Receptor Modulators; Uterus

2014